开云app官网登录入口网页版-官方正版

#GPRC5D#

2篇内容 | 1138人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2225607, encodeId=2dbf222560e96, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a> <a href='/topic/show?id=aed6822267' target=_blank style='color:#2F92EE;'>#GPRC5D#</a>, objectTitle=BJH：杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效, objectType=article, longId=843103, objectId=0286843103aa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240913/8e1f8c541ef74b3b87d1d3f8bd730228-kdyoX2gTLsR5.jpg, objectUrl=/article/show_article.do?id=0286843103aa, replyNumber=0, likeNumber=11, createdTime=2024-09-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=0286843103aa, moduleTitle=BJH：杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=0286843103aa)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225516, encodeId=4c14222551613, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a> <a href='/topic/show?id=aed6822267' target=_blank style='color:#2F92EE;'>#GPRC5D#</a>, objectTitle=【BJH】杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效, objectType=article, longId=842746, objectId=5b85842e4699, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240722/1721643024590_92910.jpg, objectUrl=/article/show_article.do?id=5b85842e4699, replyNumber=0, likeNumber=9, createdTime=2024-09-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5b85842e4699, moduleTitle=【BJH】杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5b85842e4699)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211383, encodeId=3aab221138308, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=165b836349' target=_blank style='color:#2F92EE;'>#G蛋白偶联受体#</a> <a href='/topic/show?id=aed6822267' target=_blank style='color:#2F92EE;'>#GPRC5D#</a>, objectTitle=Nat Commun：上海科技大学徐菲团队揭示抗多发性骨髓瘤抗体与人GPRC5D的结合机制, objectType=article, longId=831413, objectId=ec7c8314131e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240623/1719140519402_5579292.jpg, objectUrl=/article/show_article.do?id=ec7c8314131e, replyNumber=0, likeNumber=137, createdTime=2024-06-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ec7c8314131e, moduleTitle=Nat Commun：上海科技大学徐菲团队揭示抗多发性骨髓瘤抗体与人GPRC5D的结合机制, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=ec7c8314131e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182496, encodeId=b15c21824969f, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=833732e80d' target=_blank style='color:#2F92EE;'>#BCMA#</a> <a href='/topic/show?id=aed6822267' target=_blank style='color:#2F92EE;'>#GPRC5D#</a>, objectTitle=【Blood】多发性骨髓瘤中抗BCMA和GPRC5D双抗的疗效、安全性和耐药机制, objectType=article, longId=809876, objectId=d8d88098e66f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=d8d88098e66f, replyNumber=0, likeNumber=84, createdTime=2024-01-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=d8d88098e66f, moduleTitle=【Blood】多发性骨髓瘤中抗BCMA和GPRC5D双抗的疗效、安全性和耐药机制, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d8d88098e66f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2091132, encodeId=2e5b209113210, content=<a href='/topic/show?id=aed6822267' target=_blank style='color:#2F92EE;'>#GPRC5D#</a><a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a>, objectTitle=NEJM：靶向GPRC5D的CAR-T细胞治疗用于多发性骨髓瘤治疗, objectType=article, longId=741523, objectId=9f88e41523d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220927/2189c717336c4f9e90a033427148c144.jpg, objectUrl=/article/show_article.do?id=9f88e41523d8, replyNumber=0, likeNumber=114, createdTime=2022-09-30, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f88e41523d8, moduleTitle=NEJM：靶向GPRC5D的CAR-T细胞治疗用于多发性骨髓瘤治疗, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9f88e41523d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1993260, encodeId=5cb0199326003, content=<a href='/topic/show?id=aed6822267' target=_blank style='color:#2F92EE;'>#GPRC5D#</a>, objectTitle=Blood：JNJ-64407564，GPRC5DxCD3双特异性抗体，有望成为治疗MM的新选择！, objectType=article, longId=187901, objectId=4e1418e901c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1418e901c3, replyNumber=0, likeNumber=73, createdTime=2020-04-18, rootId=0, userName=12498ca5m83暂无昵称, userId=32a12500167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1418e901c3, moduleTitle=Blood：JNJ-64407564，GPRC5DxCD3双特异性抗体，有望成为治疗MM的新选择！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4e1418e901c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

GPRC5D

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#二甲双胍# #CAR-T细胞治疗# #GPRC5D#

BJH：杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效

2024-09-13发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #二甲双胍# #GPRC5D#

【BJH】杜鹃教授团队发现二甲双胍可增强GPRC5D CAR-T疗效

2024-09-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #G蛋白偶联受体# #GPRC5D#

Nat Commun：上海科技大学徐菲团队揭示抗多发性骨髓瘤抗体与人GPRC5D的结合机制

2024-06-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #BCMA# #GPRC5D#

【Blood】多发性骨髓瘤中抗BCMA和GPRC5D双抗的疗效、安全性和耐药机制

2024-01-18发表于陕西省

病毒猎手 (审核中...)

前往app查看评论内容

#GPRC5D##多发性骨髓瘤#

NEJM：靶向GPRC5D的CAR-T细胞治疗用于多发性骨髓瘤治疗

2022-09-30

12498ca5m83暂无昵称 (审核中...)

前往app查看评论内容

#GPRC5D#

Blood：JNJ-64407564，GPRC5DxCD3双特异性抗体，有望成为治疗MM的新选择！

2020-04-18

科室
- - 订阅+
  - 更多科室
工具
服务